EGFR and non-small cell lung carcinoma: Using proteomics analysis, we observed that NNMT were significantly increased in EGFR-TKI-resistant NSCLC cells which is consistent with the previous observation that the basal levels of NNMT expression in gefitinib-resistant NSCLC cells were overexpressed compared with their parental NSCLC cells [13].